Literature DB >> 15831465

Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.

Elizabeth Peterson-Roth1, Mindy Reynolds, George Quievryn, Anatoly Zhitkovich.   

Abstract

Chromium(VI) is a toxic and carcinogenic metal that causes the formation of DNA phosphate-based adducts. Cr-DNA adducts are genotoxic in human cells, although they do not block replication in vitro. Here, we report that induction of cytotoxicity in Cr(VI)-treated human colon cells and mouse embryonic fibroblasts requires the presence of all major mismatch repair (MMR) proteins. Cr-DNA adducts lost their ability to block replication of Cr-modified plasmids in human colon cells lacking MLH1 protein. The presence of functional mismatch repair caused induction of p53-independent apoptosis associated with activation of caspases 2 and 7. Processing of Cr-DNA damage by mismatch repair resulted in the extensive formation of gamma-H2AX foci in G(2) phase, indicating generation of double-stranded breaks as secondary toxic lesions. Induction of gamma-H2AX foci was observed at 6 to 12 h postexposure, which was followed by activation of apoptosis in the absence of significant G(2) arrest. Our results demonstrate that mismatch repair system triggers toxic responses to Cr-DNA backbone modifications through stress mechanisms that are significantly different from those for other forms of DNA damage. Selection for Cr(VI) resistant, MMR-deficient cells may explain the very high frequency of lung cancers with microsatellite instability among chromate workers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831465      PMCID: PMC1084304          DOI: 10.1128/MCB.25.9.3596-3607.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

Review 1.  One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports.

Authors:  S Langård
Journal:  Am J Ind Med       Date:  1990       Impact factor: 2.214

2.  Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage.

Authors:  P Branch; G Aquilina; M Bignami; P Karran
Journal:  Nature       Date:  1993-04-15       Impact factor: 49.962

3.  Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity.

Authors:  Mindy Reynolds; Elizabeth Peterson; George Quievryn; Anatoly Zhitkovich
Journal:  J Biol Chem       Date:  2004-04-15       Impact factor: 5.157

4.  Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility.

Authors:  Guohze Yang; Stefan J Scherer; Scarlet S Shell; Kan Yang; Mimi Kim; Martin Lipkin; Raju Kucherlapati; Richard D Kolodner; Winfried Edelmann
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

5.  Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.

Authors:  Lovorka Stojic; Nina Mojas; Petr Cejka; Massimiliano Di Pietro; Stefano Ferrari; Giancarlo Marra; Josef Jiricny
Journal:  Genes Dev       Date:  2004-06-01       Impact factor: 11.361

6.  Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival.

Authors:  Karin Drotschmann; Ryan P Topping; Jill E Clodfelter; Freddie R Salsbury
Journal:  DNA Repair (Amst)       Date:  2004-07-02

7.  Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate.

Authors:  A Zhitkovich; V Voitkun; M Costa
Journal:  Carcinogenesis       Date:  1995-04       Impact factor: 4.944

8.  Cyclin B1 expression in HeLa S3 cells studied by flow cytometry.

Authors:  S W Sherwood; D F Rush; A L Kung; R T Schimke
Journal:  Exp Cell Res       Date:  1994-04       Impact factor: 3.905

9.  An Msh2 point mutation uncouples DNA mismatch repair and apoptosis.

Authors:  Diana P Lin; Yuxun Wang; Stefan J Scherer; Alan B Clark; Kan Yang; Elena Avdievich; Bo Jin; Uwe Werling; Tchaiko Parris; Naoto Kurihara; Asad Umar; Raju Kucherlapati; Martin Lipkin; Thomas A Kunkel; Winfried Edelmann
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

10.  Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung.

Authors:  Y Suzuki; K Fukuda
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

View more
  39 in total

Review 1.  Chromium genotoxicity: A double-edged sword.

Authors:  Kristen P Nickens; Steven R Patierno; Susan Ceryak
Journal:  Chem Biol Interact       Date:  2010-04-27       Impact factor: 5.192

2.  S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde.

Authors:  Victor Chun-Lam Wong; Haley L Cash; Jessica L Morse; Shan Lu; Anatoly Zhitkovich
Journal:  Cell Cycle       Date:  2012-07-01       Impact factor: 4.534

3.  Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium.

Authors:  Hong Sun; Xue Zhou; Haobin Chen; Qin Li; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2009-04-17       Impact factor: 4.219

4.  Chromium induces chromosomal instability, which is partly due to deregulation of BubR1 and Emi1, two APC/C inhibitors.

Authors:  Liyan Hu; Xin Liu; Yana Chervona; Feikun Yang; Moon-shong Tang; Zbigniew Darzynkiewicz; Wei Dai
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

5.  Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation.

Authors:  Zhishan Wang; Jianjun Wu; Brock Humphries; Kazuya Kondo; Yiguo Jiang; Xianglin Shi; Chengfeng Yang
Journal:  Toxicol Appl Pharmacol       Date:  2018-01-31       Impact factor: 4.219

6.  Rapid DNA double-strand breaks resulting from processing of Cr-DNA cross-links by both MutS dimers.

Authors:  Mindy F Reynolds; Elizabeth C Peterson-Roth; Ivan A Bespalov; Tatiana Johnston; Volkan M Gurel; Haley L Menard; Anatoly Zhitkovich
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

Review 7.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

8.  Actin-mediated endocytosis limits intracellular Cr accumulation and Cr toxicity during chromate stress.

Authors:  Sara L Holland; Simon V Avery
Journal:  Toxicol Sci       Date:  2009-07-23       Impact factor: 4.849

9.  Src-Induced cisplatin resistance mediated by cell-to-cell communication.

Authors:  Elizabeth Peterson-Roth; Cathleen M Brdlik; Peter M Glazer
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

10.  MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea.

Authors:  J R McDaid; J Loughery; P Dunne; J C Boyer; C S Downes; R A Farber; C P Walsh
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.